Title
Category
Credits
Event date
Cost
Epilepsy Seizure Clusters: Therapeutic Advances and Emergency Plans
  • Anticonvulsants
  • Epilepsy
  • Neurology
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Participation
$0.00
Seizure clusters take a toll on patients’ emotional wellbeing, work, and quality of life. Learn from experts about new rescue treatments.
Remission and Treatment Augmentation of Depression in the United States
  • Depression
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Closer monitoring of symptoms through measurement-based care and setting symptom remission as a goal can help improve outcomes for adults with depression.
New Options for Rescue Treatment in Individuals With Epilepsy Seizure Clusters
  • Anticonvulsants
  • Epilepsy
  • Neurology
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Drs Detyniecki and Penovich identify the need for emergency seizure response plans and the new rescue treatment options that may easily be used by patients with epilepsy and their caregivers.
Determinants of Hepatitis C Virus Prevalence in People With Serious Mental Illness: A Systematic Review and Meta-Analysis
  • Hepatitis
  • Medical Conditions
  • Neuropsychiatric Disorders
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Increased screening for hepatitis C virus among people with serious mental illness is key to achieving global eradication of the virus.
Identification and Management of Night Eating Syndrome in the Adolescent and Young Adult Population
  • Eating Disorders
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Night eating syndrome is a condition that requires early identification and management, especially among adolescents who develop symptoms during the transition into adulthood.
Measurement-Based Care for Psychotic Disorders in the Veterans Health Administration: Current Practices and Future Directions
  • Psychotic Disorders
  • Veterans and Military Issues
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Measurement-based care (MBC) can improve patient outcomes, but data on its use in psychosis are sparse. This study examined the use of patient-reported outcome measures in veterans with psychosis to identify candidate measures for psychosis-related MBC.
Suicide Risk in a National VA Sample: Roles of Psychiatric Diagnosis, Behavior Regulation, Substance Use, and Smoking
  • Bipolar Disorder
  • Schizophrenia/ Schizoaffective Disorders
  • Smoking
  • Substance Use Disorders
  • Suicide
  • Veterans and Military Issues
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
Predicting suicide is difficult, as suicidal behavior is not linked solely to any single behavior or psychiatric diagnosis. This study compared risk of suicidal behavior among a transdiagnostic sample of Veterans with varying disorders and behaviors.
The Co-occurrence of Gastrointestinal Symptoms and Psychosis: Diagnostic Considerations
  • Psychotic Disorders
  • Gastroenterology
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
There are numerous clinical scenarios in which gastrointestinal and psychotic symptoms commonly co-occur; thus, it is important that both psychiatrists and primary care physicians have a familiarity with the differential diagnosis.
Treatment-Resistant Mood Disorders in LGBTQ People: A Retrospective Study of Clinical Features and Response to Electroconvulsive Therapy
  • Mood Disorders
  • Depression
  • Electroconvulsive Therapy
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
In this chart review, LGBTQ people with treatment-resistant mood disorders had clinical features linked to worse outcomes, but their improvement with ECT was similar to that seen in non-LGBTQ patients.
Improving Standards of Care in Type 2 Diabetes with Chronic Kidney Disease: Integrating the Non-Steroidal Mineralocorticoid Antagonist Class in Cardiorenal Medicine
  • Renal Disease
  • Primary Care
  • Patient/Physician Communication
  • Side Effects
  • Cardiology
  • Metabolic Disorders
  • Diagnostic Tools
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
$0.00
How to screen UACR and eGFR levels, implement selective non-steroidal MRA therapies, and mitigate the risk of hyperkalemia to prevent CKD disease progression

Pages